
Ethyricef S 250mg/125mg Injection
Marketer
Ethyrial Pharmaceuticals
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Ethyricef S 250mg/125mg Injection
Cefixime and Sulbactam injection (250mg/125mg), a dual-action antibiotic, combats a range of bacterial infections by inhibiting microbial growth and propagation. Administration must be strictly under medical guidance. Complete the prescribed dosage; premature cessation can reduce its effectiveness. Regularly scheduled doses are crucial. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe reactions necessitate immediate medical attention. Allergic responses (rash, itching, swelling, dyspnea) require urgent medical help. Inform your physician about all other medications before commencing treatment. Pregnant or lactating individuals should seek medical counsel. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, avoid driving if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and sufficient hydration promote faster recovery. Monitoring via laboratory tests may be necessary to assess the drug's impact.
Uses of Ethyricef S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Ethyricef S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Ethyricef S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Ethyricef S 250mg/125mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is not advised.
How Ethyricef S 250mg/125mg Injection works:
Ethyricef S injection, containing 250mg Ceftriaxone and 125mg Sulbactam, combines an antibiotic with a beta-lactamase inhibitor. Ceftriaxone's antibacterial action disrupts bacterial cell wall synthesis, hindering their survival. Sulbactam's role is to counteract bacterial resistance mechanisms, thus optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Ethyricef S 250mg/125mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Ethyricef S (250mg/125mg) is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human studies are scarce.
Breast feedingCAUTION
The administration of Ethyricef S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the course of maternal treatment and until the medication is fully cleared from the mother's system.
DrivingUNSAFE
Administering Ethyricef S 250mg/125mg Injection could lead to drowsiness, blurred vision, or dizziness. Refrain from operating a vehicle if such effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ethyricef S 250mg/125mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
Patients with severe hepatic impairment should use Ethyricef S 250mg/125mg Injection cautiously, potentially requiring dosage modification. For patients with mild to moderate liver disease, dose adjustment of Ethyricef S 250mg/125mg Injection is unnecessary; however, physician consultation is advised.
What if you forget to take Ethyricef S 250mg/125mg Injection :
Should you inadvertently omit a scheduled dose of Ethyricef S 250mg/125mg Injection, seek advice from your physician.
Facts to Know About Ethyricef S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Antimicrobials |
